112 related articles for article (PubMed ID: 34597175)
1. Could 675-nm Laser Treatment Be Effective for Facial Melasma Even in Darker Phototype?
Bonan P; Verdelli A; Pieri L; Fusco I
Photobiomodul Photomed Laser Surg; 2021 Oct; 39(10):634-636. PubMed ID: 34597175
[No Abstract] [Full Text] [Related]
2. Treatment of melasma with mixed parameters of 1,064-nm Q-switched Nd:YAG laser toning and an enhanced effect of ultrasonic application of vitamin C: a split-face study.
Lee MC; Chang CS; Huang YL; Chang SL; Chang CH; Lin YF; Hu S
Lasers Med Sci; 2015 Jan; 30(1):159-63. PubMed ID: 25073866
[TBL] [Abstract][Full Text] [Related]
3. Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1927-nm fractional low-powered diode laser.
Geddes ER; Stout AB; Friedman PM
Lasers Surg Med; 2017 Jan; 49(1):20-26. PubMed ID: 28134994
[TBL] [Abstract][Full Text] [Related]
4. A New 675 nm Laser Device in the Treatment of Melasma: Results of a Prospective Observational Study.
Nisticò SP; Tolone M; Zingoni T; Tamburi F; Scali E; Bennardo L; Cannarozzo G
Photobiomodul Photomed Laser Surg; 2020 Sep; 38(9):560-564. PubMed ID: 32833576
[No Abstract] [Full Text] [Related]
5. Therapeutic outcome of melasma treatment by dual-wavelength (511 and 578 nm) laser in patients with skin phototypes III-V.
Eimpunth S; Wanitphakdeedecha R; Triwongwaranat D; Varothai S; Manuskiatti W
Clin Exp Dermatol; 2014 Apr; 39(3):292-7. PubMed ID: 24635063
[TBL] [Abstract][Full Text] [Related]
6. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser.
Alsaad SM; Ross EV; Mishra V; Miller L
Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141
[TBL] [Abstract][Full Text] [Related]
7. A split face randomized controlled trial comparing 1,064 nm Q-switched Nd-YAG laser and modified Kligman's formulation in patients with melasma in darker skin.
Dev T; Sreenivas V; Sharma VK; Sahni K; Bhari N; Sethuraman G
Int J Dermatol; 2020 Dec; 59(12):1525-1530. PubMed ID: 33017045
[TBL] [Abstract][Full Text] [Related]
8. The 675-nm wavelength for treating facial melasma.
Coricciati L; Gabellone M; Donne PD; Pennati BM; Zingoni T
Skin Res Technol; 2023 Aug; 29(8):e13434. PubMed ID: 37632189
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of 1927 nm fractional Thulium fiber laser for the treatment of melasma: a retrospective study of 100 patients.
Kurmuş G; Tatlıparmak A; Aksoy B; Koç E; Aşiran Serdar Z; Ergin C
J Cosmet Laser Ther; 2019; 21(7-8):408-411. PubMed ID: 31690148
[No Abstract] [Full Text] [Related]
10. Long-term results in low-fluence 1064-nm Q-Switched Nd:YAG laser for melasma: Is it effective?
Gokalp H; Akkaya AD; Oram Y
J Cosmet Dermatol; 2016 Dec; 15(4):420-426. PubMed ID: 27349828
[TBL] [Abstract][Full Text] [Related]
11. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
[TBL] [Abstract][Full Text] [Related]
12. Effects of a fractional picosecond 1,064 nm laser for the treatment of dermal and mixed type melasma.
Chalermchai T; Rummaneethorn P
J Cosmet Laser Ther; 2018 Jun; 20(3):134-139. PubMed ID: 29020467
[TBL] [Abstract][Full Text] [Related]
13. Treatment of melasma with low fluence, large spot size, 1064-nm Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser for the treatment of melasma in Fitzpatrick skin types II-IV.
Brown AS; Hussain M; Goldberg DJ
J Cosmet Laser Ther; 2011 Dec; 13(6):280-2. PubMed ID: 21992660
[TBL] [Abstract][Full Text] [Related]
14. Low-dose 1064-nm Q-switched Nd:YAG laser for the treatment of melasma.
Choi M; Choi JW; Lee SY; Choi SY; Park HJ; Park KC; Youn SW; Huh CH
J Dermatolog Treat; 2010 Jul; 21(4):224-8. PubMed ID: 20509814
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of Q-switched 1,064-nm neodymium-doped yttrium aluminum garnet laser treatment of melasma.
Zhou X; Gold MH; Lu Z; Li Y
Dermatol Surg; 2011 Jul; 37(7):962-70. PubMed ID: 21615824
[TBL] [Abstract][Full Text] [Related]
16. Treatment of melasma with the 1,927-nm fractional thulium fiber laser: a retrospective analysis of 20 cases with long-term follow-up.
Niwa Massaki AB; Eimpunth S; Fabi SG; Guiha I; Groff W; Fitzpatrick R
Lasers Surg Med; 2013 Feb; 45(2):95-101. PubMed ID: 23255085
[TBL] [Abstract][Full Text] [Related]
17. A Randomized, Controlled, Split-Face Study of the Efficacy of a Picosecond Laser in the Treatment of Melasma.
Lyons AB; Moy RL; Herrmann JL
J Drugs Dermatol; 2019 Nov; 18(11):1104-1107. PubMed ID: 31741350
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of 694-nm Q-switched ruby fractional laser treatment of melasma in female Korean patients.
Jang WS; Lee CK; Kim BJ; Kim MN
Dermatol Surg; 2011 Aug; 37(8):1133-40. PubMed ID: 21585597
[TBL] [Abstract][Full Text] [Related]
19. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma.
Ustuner P; Balevi A; Ozdemir M
J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378
[TBL] [Abstract][Full Text] [Related]
20. Melanocyte activation and skin barrier disruption induced in melasma patients after 1064 nm Nd:YAG laser treatment.
Gao YL; Jia XX; Wang M; Hua Y; Zheng H; Xiang WZ; Song XZ
Lasers Med Sci; 2019 Jun; 34(4):767-771. PubMed ID: 30302596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
